Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2

Status

Completed 18Terminated 8Recruiting 8Active not recruiting 6Withdrawn 2Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Pancreatic Neoplasms 17Breast Neoplasms 10Triple Negative Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Parkinson Disease 4, Autosomal Dominant Lewy Body 3Stomach Neoplasms 2Pancreatic Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Cancer 1Sarcoma 1Oropharyngeal Neoplasms 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Laryngeal Neoplasms 1Kidney Neoplasms 1Invasive Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Gliosarcoma 1

Interventions

Carboplatin 25Paclitaxel 24pembrolizumab 22Cyclophosphamide 15Gemcitabine 10Capecitabine 10Doxorubicin 9Specimen Handling 8Nivolumab 8Taxes 7Magnetic Resonance Spectroscopy 7sacituzumab govitecan 6olaparib 6Cisplatin 6Albumin-Bound Paclitaxel 6eribulin 5durvalumab 5atezolizumab 5Radiotherapy 5Epirubicin 5130-nm albumin-bound paclitaxel 5capivasertib 4Docetaxel 4Biopsy 4niraparib 3Vinorelbine 3Radiation 3Blood Specimen Collection 3trastuzumab deruxtecan 2toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Triple Negative Breast Neoplasms × Albumin-Bound Paclitaxel × Clear all
NCT02957968 2026-04-21

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

Virginia Commonwealth University

Phase 2 Active not recruiting
46 enrolled 21 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05382299 2026-04-06

ASCENT-03

Gilead Sciences

Phase 3 Active not recruiting
623 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01525966 2026-03-30

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
67 enrolled 12 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05382286 2025-09-18

ASCENT-04

Gilead Sciences

Phase 3 Active not recruiting
443 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02788981 2025-06-10

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

University of Chicago

Phase 2 Active not recruiting
29 enrolled 11 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04418154 2024-05-21

NeoTENNIS

Fudan University

Phase 2 Active not recruiting
70 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡